Uncovering BAP1 deubiquitination landscape enhances mechanism elucidation and therapeutic precision for BAP1-deficient pancancers

Journal:

Science Translational Medicine

Published:

2026-04-01

DOI:

10.1126/scitranslmed.adr6668

Affiliations:

30

Authors:

41

Go to article

Institutions	Authors	Share
National Cancer Centre Singapore (NCCS), Singapore	9.500000	0.23
Duke-NUS Medical School, Singapore	7.583333	0.18
Khon Kaen University, Thailand	4.000000	0.10
Institute of Molecular and Cell Biology (IMCB), A*STAR, Singapore	3.583333	0.09
State Key Laboratory of Oncology in South China, SYSUCC, China	3.250000	0.08
Genome Institute of Singapore (GIS), A*STAR, Singapore	2.583333	0.06
KK Women's and Children's Hospital (KKH), Singapore	2.000000	0.05
National University of Singapore (NUS), Singapore	1.583333	0.04
Second Affiliated Hospital, SCUT, China	1.000000	0.02
Princess Margaret Cancer Centre, U of T, Canada	1.000000	0.02
Houston Methodist Hospital, United States of America (USA)	1.000000	0.02
Singapore General Hospital (SGH), Singapore	1.000000	0.02
Singapore National Laboratory for Mass Spectrometry (SingMass), Singapore	0.666667	0.02
Human Oncology and Pathogenesis Program (HOPP), MSKCC, United States of America (USA)	0.500000	0.01
Harold C. Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, United States of America (USA)	0.500000	0.01
The University of Texas Southwestern Medical Center (UT Southwestern Medical Center), United States of America (USA)	0.500000	0.01
Oklahoma State University, United States of America (USA)	0.250000	0.01
Hainan Medical University, China	0.250000	0.01
The Third Affiliated Hospital, GMU, China	0.250000	0.01

Interested in Oncology and Carcinogenesis?